\setlength{\LTpost}{0mm}
\begin{longtable}{llrrrrr}
\toprule
\multicolumn{2}{c}{ATC sub-group} & \multicolumn{2}{c}{\# of users} & \multicolumn{3}{c}{Cox hazard risk (HR) estimates} \\ 
\cmidrule(lr){1-2} \cmidrule(lr){3-4} \cmidrule(lr){5-7}
symbol & description & non-PD users & PD users & HR & 95\% CI & FDR p-value\textsuperscript{\textit{1}} \\ 
\midrule
\multicolumn{7}{l}{drugs decreasing PD risk} \\ 
\midrule
R03 & Drugs For Obstructive Airway Diseases & $617,770$ & $2,250$ & $0.86$ & $0.82$–$0.90$ & $8.97 \times 10^{-10}$ \\ 
N07 & Other Nervous System Drugs & $130,499$ & $220$ & $0.68$ & $0.60$–$0.77$ & $4.11 \times 10^{-8}$ \\ 
H02 & Corticosteroids For Systemic Use & $574,399$ & $1,801$ & $0.88$ & $0.84$–$0.93$ & $1.44 \times 10^{-5}$ \\ 
C09 & Agents Acting On The Renin-Angiotensin System & $958,036$ & $5,656$ & $0.92$ & $0.89$–$0.95$ & $2.38 \times 10^{-5}$ \\ 
S03 & Ophthalmological And Otological Preparations & $166,253$ & $549$ & $0.83$ & $0.77$–$0.91$ & $3.10 \times 10^{-4}$ \\ 
P01 & Antiprotozoals & $196,008$ & $469$ & $0.85$ & $0.78$–$0.93$ & $3.88 \times 10^{-3}$ \\ 
J01 & Antibacterials For Systemic Use & $2,288,337$ & $8,691$ & $0.95$ & $0.92$–$0.98$ & $2.12 \times 10^{-2}$ \\ 
L01 & Antineoplastic Agents & $39,989$ & $58$ & $0.69$ & $0.55$–$0.87$ & $2.29 \times 10^{-2}$ \\ 
J07 & Vaccines & $190,868$ & $563$ & $0.89$ & $0.82$–$0.96$ & $4.90 \times 10^{-2}$ \\ 
R05 & Cough And Cold Preparations & $1,025,264$ & $3,691$ & $0.95$ & $0.91$–$0.98$ & $4.90 \times 10^{-2}$ \\ 
\midrule
\multicolumn{7}{l}{drugs increasing PD risk} \\ 
\midrule
N06 & Psychoanaleptics & $703,424$ & $4,107$ & $1.94$ & $1.87$–$2.01$ & $1.40 \times 10^{-284}$ \\ 
G04 & Urologicals & $491,640$ & $3,954$ & $1.48$ & $1.42$–$1.53$ & $4.90 \times 10^{-86}$ \\ 
N05 & Psycholeptics & $1,182,693$ & $6,465$ & $1.40$ & $1.35$–$1.44$ & $4.90 \times 10^{-86}$ \\ 
N03 & Antiepileptics & $258,953$ & $1,184$ & $1.48$ & $1.40$–$1.57$ & $4.11 \times 10^{-38}$ \\ 
A06 & Drugs For Constipation & $160,133$ & $622$ & $1.60$ & $1.49$–$1.73$ & $8.22 \times 10^{-34}$ \\ 
C07 & Beta Blocking Agents & $729,649$ & $5,354$ & $1.21$ & $1.17$–$1.26$ & $6.04 \times 10^{-27}$ \\ 
B01 & Antithrombotic Agents & $969,615$ & $7,013$ & $1.17$ & $1.13$–$1.21$ & $5.50 \times 10^{-18}$ \\ 
A11 & Vitamins & $394,032$ & $1,522$ & $1.24$ & $1.18$–$1.31$ & $4.21 \times 10^{-14}$ \\ 
S01 & Ophthalmologicals & $1,149,495$ & $5,232$ & $1.14$ & $1.10$–$1.17$ & $3.33 \times 10^{-12}$ \\ 
N02 & Analgesics & $1,752,394$ & $6,745$ & $1.12$ & $1.09$–$1.16$ & $8.96 \times 10^{-11}$ \\ 
M05 & Drugs For Treatment Of Bone Diseases & $165,635$ & $1,043$ & $1.26$ & $1.18$–$1.34$ & $2.74 \times 10^{-10}$ \\ 
C01 & Cardiac Therapy & $309,449$ & $2,161$ & $1.17$ & $1.12$–$1.23$ & $2.87 \times 10^{-10}$ \\ 
B03 & Antianemic Preparations & $406,710$ & $1,714$ & $1.17$ & $1.11$–$1.23$ & $2.13 \times 10^{-8}$ \\ 
D01 & Antifungals For Dermatological Use & $362,680$ & $1,513$ & $1.17$ & $1.12$–$1.24$ & $2.13 \times 10^{-8}$ \\ 
A12 & Mineral Supplements & $363,723$ & $1,593$ & $1.17$ & $1.11$–$1.24$ & $6.23 \times 10^{-8}$ \\ 
H01 & Pituitary And Hypothalamic Hormones And Analogues & $39,136$ & $98$ & $1.77$ & $1.45$–$2.15$ & $2.79 \times 10^{-7}$ \\ 
A03 & Drugs For Functional Gastrointestinal Disorders & $191,041$ & $584$ & $1.24$ & $1.14$–$1.34$ & $3.53 \times 10^{-6}$ \\ 
A02 & Drugs For Acid Related Disorders & $865,821$ & $3,704$ & $1.10$ & $1.06$–$1.14$ & $2.38 \times 10^{-5}$ \\ 
M01 & Antiinflammatory And Antirheumatic Products & $1,974,460$ & $7,903$ & $1.07$ & $1.03$–$1.10$ & $1.13 \times 10^{-3}$ \\ 
G03 & Sex Hormones And Modulators Of The Genital System & $740,155$ & $2,167$ & $1.10$ & $1.04$–$1.15$ & $5.49 \times 10^{-3}$ \\ 
A01 & Stomatological Preparations & $67,135$ & $229$ & $1.23$ & $1.09$–$1.40$ & $1.75 \times 10^{-2}$ \\ 
\bottomrule
\end{longtable}
\begin{minipage}{\linewidth}
\textsuperscript{\textit{1}}p-value adjusted for false discovery rate\\
\end{minipage}

